HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.00
+2.50 (6.67%)
Nov 13, 2026, 1:30 PM CST

HeXun Biosciences Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
142.73111.91147.2233.49-5.19-42.99
Depreciation & Amortization
30.4927.9123.5219.114.1911.43
Other Amortization
1.041.041.21.20.530.48
Loss (Gain) From Sale of Assets
1.041.620.010.05-0.02-0.2
Stock-Based Compensation
73.62--0.3-
Other Operating Activities
15.5-4.3613.97-0.07-0.050.47
Change in Accounts Receivable
-34.7710.12-62.39-17.3-4.98-
Change in Inventory
-8.069.56-10.98-4.6--
Change in Accounts Payable
5.34-1.071.81-0.80.42-4.3
Change in Unearned Revenue
-8.755.266.97-3.375.1-
Change in Other Net Operating Assets
-15.86-1.71-0.415.390.93-0.39
Operating Cash Flow
105.42163.89120.9243.0911.23-35.5
Operating Cash Flow Growth
-40.63%35.54%180.62%283.77%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-34.08-27.29-37.29-20.67-1.23-
Sale of Property, Plant & Equipment
0.19---0.138.84
Sale (Purchase) of Intangibles
-1.66-1.57--0.64-5.96-
Investment in Securities
-45.65-129.43-100--72-
Other Investing Activities
2-0.09--3.97--35.78
Investing Cash Flow
-79.2-158.38-137.29-25.28-79.05-26.95

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--3.81-40.31-4.88-2.46-2.01
Lease Payments
-3.93-3.81-2.85-2.73-2.07-2.01
Net Debt Issued (Repaid)
-3.93-3.81-40.31-4.88-2.46-2.01
Issuance of Common Stock
266.34--12510578
Other Financing Activities
-0.65.5----0.2
Financing Cash Flow
247.531.69-40.31120.12102.5475.79

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
273.757.21-56.68137.9334.7213.34

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
71.34136.6183.6322.4210-35.5
Free Cash Flow Growth
-54.34%63.36%272.98%124.19%--
Free Cash Flow Margin
23.38%46.59%29.20%17.17%20.22%-
Free Cash Flow Per Share
1.502.971.820.490.27-1.16
Levered Free Cash Flow
43.0394.9133.79.680.46-
Unlevered Free Cash Flow
43.6895.6134.4310.841.48-
Free Cash Flow After Leases
67.41132.880.7719.77.93-37.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.11.11.241.791.641.57
Cash Income Tax Paid
18.3318.330.17---
Change in Working Capital
-62.122.16-64.99-10.681.47-4.69